Will children with cancer benefit from the new European Paediatric Medicines Regulation?VASSAL, Gilles.European journal of cancer (1990). 2009, Vol 45, Num 9, pp 1535-1546, issn 0959-8049, 12 p.Article

La signature génique au service de la thérapie = Gene expression and cancer prognosisVASSAL, Gilles; LOCHOUARN, Martine.Concours médical (Paris). 2003, Vol 125, Num 25, pp 1422-1424, issn 0010-5309, 3 p.Article

Has chemotherapy reached its limits in pediatric cancers? CommentaryVASSAL, Gilles; LOWIS, S; NEWELL, D. R et al.European journal of cancer (1990). 2005, Vol 41, Num 4, pp 564-577, issn 0959-8049, 14 p.Article

Les essais cliniques en cancérologie pédiatrique: Recommandations pour le développement des nouveaux agents anticancéreux = Clinical trials in paediatric oncology: Recommendations for the development of new anticancer agentsVASSAL, Gilles; MERY-MIGNARD, Dominique; CAULIN, Charles et al.Thérapie (Paris). 2003, Vol 58, Num 3, pp 229-246, issn 0040-5957, 17 p.Conference Paper

Busulfan, greffe de moelle et tumeurs cérébrales: Pharmacotoxicologie clinique et nouveaux modèles expérimentaux = Busulfan, bone marrow transplantation and brain tumors: Clinical pharmacotoxicology and new experimental modelsVassal, Gilles; Gouyette, A.1993, 187 p.Thesis

Liquid chromatography-tandem mass spectrometry assay of reduced and oxidized glutathione and main precursors in mice liverBOULIGAND, Jérome; DEROUSSENT, Alain; PACI, Angelo et al.Journal of chromatography. B. 2006, Vol 832, Num 1, pp 67-74, issn 1570-0232, 8 p.Article

High-performance thin-layer chromatography with a derivatization procedure, a suitable method for the identification and the quantitation of busulfan in various pharmaceutical productsBOULIGAND, Jérome; PACI, Angelo; MERCIER, Lionel et al.Journal of pharmaceutical and biomedical analysis. 2004, Vol 34, Num 3, pp 525-530, issn 0731-7085, 6 p.Article

Operating characteristics of two independent sample design in phase I trials in paediatric oncologyRAPHAËL, Mathilde; LE DELEY, Marie-Cécile; VASSAL, Gilles et al.European journal of cancer (1990). 2010, Vol 46, Num 8, pp 1392-1398, issn 0959-8049, 7 p.Article

Interaction between methotrexate and ciprofloxacinDALLE, Jean-Hugues; AUVRIGNON, Anne; VASSAL, Gilles et al.Journal of pediatric hematology/oncology. 2002, Vol 24, Num 4, pp 321-322, issn 1077-4114Article

Recherche précompétitive, une mise en synergie des ressources publiques et privées: pour quels objectifs, comment et dans quel cadre juridique ?VASSAL, Gilles; NEVES, Carole; ARNAUD, Olivier et al.Thérapie (Paris). 2011, Vol 66, Num 4, pp 301-307, issn 0040-5957, 7 p.Article

p53 pathway dysfunction in primary childhood ependymomasGASPAR, Nathalie; GRILL, Jacques; GEOERGER, Birgit et al.Pediatric blood & cancer. 2006, Vol 46, Num 5, pp 604-613, issn 1545-5009, 10 p.Article

High cumulative rate of secondary leukemia after continuous etoposide treatment for solid tumors in children and young adultsLE DELEY, Marie-Cécile; VASSAL, Gilles; TAÏBI, Ahmed et al.Pediatric blood & cancer. 2005, Vol 45, Num 1, pp 25-31, issn 1545-5009, 7 p.Article

Simultaneous determination of gemcitabine and gemcitabine-squalene by liquid chromatography-tandem mass spectrometry in human plasmaKHOURY, Hania; DEROUSSENT, Alain; HARIVARDHAN REDDY, L et al.Journal of chromatography. B. 2007, Vol 858, Num 1-2, pp 71-78, issn 1570-0232, 8 p.Article

High level of apoptosis and low AKT activation in mass screening as opposed to standard neuroblastomaSARTELET, Hervé; OHTA, Shigeru; OLIGNY, Luc L et al.Histopathology. 2010, Vol 56, Num 5, pp 607-616, issn 0309-0167, 10 p.Article

MGMT-Independent Temozolomide Resistance in Pediatric Glioblastoma Cells Associated with a PI3-Kinase-Mediated HOX/Stem Cell Gene SignatureGASPAR, Nathalie; MARSHAL, Lynley; HARGRAVE, Darren et al.Cancer research (Chicago, Ill.). 2010, Vol 70, Num 22, pp 9243-9252, issn 0008-5472, 10 p.Article

Phase II trial of irinotecan in children with relapsed or refractory rhabdomyosarcoma : A joint study of the french society of pediatric oncology and the United Kingdom Children's cancer study groupVASSAL, Gilles; COUANET, Dominique; CISAR, Laura et al.Journal of clinical oncology. 2007, Vol 25, Num 4, pp 356-361, issn 0732-183X, 6 p.Article

Synthesis and biological evaluation of two glycerolipidic prodrugs of didanosine for direct lymphatic delivery against HIVLALANNE, Muriel; PACI, Angelo; ANDRIEUX, Karine et al.Bioorganic & medicinal chemistry letters (Print). 2007, Vol 17, Num 8, pp 2237-2240, issn 0960-894X, 4 p.Article

In vivo echographic evidence of tumoral vascularization and microenvironment interactions in metastatic orthotopic human neuroblastoma xenograftsJOSEPH, Jean-Marc; GROSS, Nicole; LASSAU, Nathalie et al.International journal of cancer. 2005, Vol 113, Num 6, pp 881-890, issn 0020-7136, 10 p.Article

In vivo treatment with CPT-11 leads to differentiation of neuroblastoma xenografts and topoisomerase I alterationsSANTOS, Alexandre; CALVET, Loreley; TERRIER-LACOMBE, Marie-Josee et al.Cancer research (Baltimore). 2004, Vol 64, Num 9, pp 3223-3229, issn 0008-5472, 7 p.Article

Les adénovirus réplicatifs conditionnels : un second souffle pour la thérapie génique du cancer = Conditionally replicative adenoviruses: a second wind for cancer gene therapyGRILL, Jacques; GEOERGER, Birgit; LAMFERS, Martine et al.Bulletin du cancer. 2003, Vol 90, Num 12, pp 1039-1048, issn 0007-4551, 10 p.Article

A European Network of Paediatric Research at the European Medicines Agency (Enpr-EMA)RUPERTO, Nicolino; EICHLER, Irmgard; HEROLD, Ralf et al.Archives of disease in childhood. 2012, Vol 97, Num 3, pp 185-188, issn 0003-9888, 4 p.Article

Pharmacokinetic Behavior and Appraisal of Intravenous Busulfan Dosing in Infants and Older Children: The Results of a Population Pharmacokinetic Study From a Large Pediatric Cohort Undergoing Hematopoietic Stem-Cell TransplantationPACI, Angelo; VASSAL, Gilles; PETAIN, Aurélie et al.Therapeutic drug monitoring. 2012, Vol 34, Num 2, pp 198-208, issn 0163-4356, 11 p.Article

A new nanomedicine based on didanosine glycerolipidic prodrug enhances the long term accumulation of drug in a HIV sanctuarySKANJI, Rym; ANDRIEUX, Karine; PACI, Angelo et al.International journal of pharmaceutics (Print). 2011, Vol 414, Num 1-2, pp 285-297, issn 0378-5173, 13 p.Article

The selective VEGFR1-3 inhibitor axitinib (AG-013736) shows antitumor activity in human neuroblastoma xenograftsRÖSSLER, Jochen; MONNET, Yann; FARACE, Francoise et al.International journal of cancer (Print). 2011, Vol 128, Num 11, pp 2748-2758, issn 0020-7136, 11 p.Article

Induction of glutathione synthesis explains pharmacodynamics of high-dose busulfan in mice and highlights putative mechanisms of drug interactionBOULIGAND, Jérome; DEROUSSENT, Alain; SIMONNARD, Nicolas et al.Drug metabolism and disposition. 2007, Vol 35, Num 2, pp 306-314, issn 0090-9556, 9 p.Article